| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 1e-05 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |